Developmental Neuroscience
Original Paper
Melatonin Provides Neuroprotection in the Late-Gestation Fetal Sheep Brain in Response to Umbilical Cord OcclusionMiller S.L. · Yan E.B. · Castillo-Meléndez M. · Jenkin G. · Walker D.W.Fetal and Neonatal Research Group, Department of Physiology, School of Biomedical Sciences, Monash University, Clayton, Australia
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: August 13, 2004
Accepted: December 20, 2004
Published online: July 19, 2005
Issue release date: March – August
Number of Print Pages: 11
Number of Figures: 5
Number of Tables: 1
ISSN: 0378-5866 (Print)
eISSN: 1421-9859 (Online)
For additional information: https://www.karger.com/DNE
Abstract
Oxygen free radicals, including the highly toxic hydroxyl radical (·OH), initiate lipid peroxidation and DNA/RNA fragmentation and damage cells. The pineal hormone melatonin is an antioxidant and powerful scavenger of ·OH. We hypothesized that maternally administered melatonin could reduce ·OH formation, lipid peroxidation, and DNA/RNA damage in the fetal brain in response to asphyxia. In 15 fetal sheep, extracellular ·OH was measured by microdialysis in white and gray matter of the parasagittal cortex. In 10 fetuses, asphyxia was induced by umbilical cord occlusion for 10 min using an inflatable cuff – the ewes of these fetuses received either intravenous melatonin (1 mg bolus, then 1 mg/h for 2 h; n = 5) or vehicle (1% ethanol in saline; n = 5), and results were compared to fetuses with sham cord occlusion and vehicle-infused ewes (n = 5). Hypoxemia, acidemia, hypertension and bradycardia produced by cord occlusion was similar in the melatonin- and vehicle-treated groups. In the vehicle-treated group, cord occlusion resulted in a significant increase in ·OH in gray matter at 8–9.5 h after occlusion (p < 0.05); in contrast, there was no ·OH change in the melatonin-treated group. After cord occlusion, lipid peroxidation (4-hydroxynonenal immunoreactivity) found throughout the brain of vehicle-infused ewes was significantly less in the melatonin-infused group. Melatonin had no significant effect on the distribution of DNA/RNA fragmentation, as shown by 8-hydroxydeoxyguanosine immunoreactivity. Thus, brief asphyxia results in significant and delayed entry of ·OH into the extracellular space of cortical gray matter in the fetal sheep brain, and melatonin given to the mother at the time of the insult abrogates this increase. Melatonin, in reducing O2 free radical production, may be an effective neuroprotective treatment for the fetus.
© 2005 S. Karger AG, Basel
Related Articles:
References
- Aruoma OI, Halliwell B, Gajewski E, Dizdaroglu M (1989): Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 264:20509–20512.
-
Asano T, Matsui T, Takuwa Y (1991): Lipid peroxidation, protein kinase C and cerebral ischemia. Crit Rev Neurosurg 1:361–379.
- Bagenholm R, Nilsson U, Gotborg C, Kjellmer I (1998): Free radicals are formed in the brain of fetal sheep during reperfusion after cerebral ischemia. Pediatr Res 43:271–275.
- Barlow-Walden LR, Reiter RJ, Abe M, Pablos M, Menendez-Pelaez A, Chen LD, Poeggeler B (1995): Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 26:497–502.
-
Becker LB, vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT (1999): Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol 277:H2240–H2246.
- Bosch-Morell F, Flohe L, Marin N, Romero FJ (1999): 4-Hydroxynonenal inhibits glutathione peroxidase: Protection by glutathione. Free Radic Biol Med 26:1383–1387.
- Castagne V, Gautschi M, Lefevre K, Posada A, Clarke PG (1999): Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59:397–423.
- Castillo-Melendez M, Chow JA, Walker DW (2004): Lipid peroxidation, caspase-3 immunoreactivity, and pyknosis in late-gestation fetal sheep brain after umbilical cord occlusion. Pediatr Res 55:864–871.
-
Dianzani MU, Paradisi L, Barera G, Rossi MA, Parola M (1989): The action of 4-hydroxynonenal on the plasma membrane enzymes from rat hepatocytes; in Beumont PC, Deeble DJ, Parsons BJ, Rice-Evans C (eds): Free Radicals, Metal Ions and Biopolymers. London, Richelieu Press, pp 329–346.
- Dirnagl U, Lindauer U, Them A, Schreiber S, Pfister HW, Koedel U (1995): Global cerebral ischemia in the rat: Online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab 15:929–940.
- Esterbauer H, Schaur RJ, Zollner H (1991): Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128.
- Fantel AG, Mackler B, Stamps LD, Tran TT, Person RE (1998): Reactive oxygen species and DNA oxidation in fetal rat tissues. Free Radic Biol Med 25:95–103.
- Fowden AL, Harding R, Ralph MM, Thorburn GD (1987): The nutritional regulation of plasma prostaglandin E concentrations in the fetus and pregnant ewe in late gestation. J Physiol 394:1–42.
- Halliwell B, Aruoma OI (1991): DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 281:9–19.
- Higuchi Y (2003): Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol 66:1527–1535.
- Ikeda T, Choi B, Yee S, Murata Y, Quilligan E (1999): Oxidative stress, brain white matter damage and intrauterine asphyxia in fetal lambs. Int J Dev Neurosci 17:1–14.
- Ikeda T, Murata Y, Quilligan EJ, Choi BH, Parer JT, Doi S, Park SD (1998): Physiologic and histologic changes in near-term fetal lambs exposed to asphyxia by umbilical cord occlusion. Am J Obstet Gynecol 178:474–478.
- Imlay JA, Chin SM, Linn S (1998): Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240:1302–1309.
- Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C (1999): Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 50:271–279.
- Johnston BM, Mallard EC, Williams CE, Gluckman PD (1996): Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest 97:300–308.
- Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, Waeg G, Mattson MP (1997): 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80:685–696.
-
Kevin LG, Camara AK, Riess ML, Novalija E, Stowe DF (2003): Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 284:H566–H574.
- Leach C, Thorburn GD (1980): A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release. Prostaglandins 20:51–56.
- Lee HM, Wang C, Hu Z, Greeley GH, Makalowski W, Hellmich HL, Englander EW (2002): Hypoxia induces mitochondrial DNA damage and stimulates expression of a DNA repair enzyme, the Escherichia coli MutY DNA glycosylase homolog (MYH), in vivo, in the rat brain. J Neurochem 80:928–937.
- Lievre V, Becuwe P, Bianchi A, Bossenmeyer-Pourie C, Koziel V, Franck P, Nicolas MB, Dauca M, Vert P, Daval JL (2001): Intracellular generation of free radicals and modifications of detoxifying enzymes in cultured neurons from the developing rat forebrain in response to transient hypoxia. Neuroscience 10:287–297.
- Lust WD, Taylor C, Pundik S, Selman WR, Ratcheson RA (2002): Ischemic cell death: Dynamics of delayed secondary energy failure during reperfusion following focal ischemia. Metab Brain Dis 17:113–121.
- McCracken E, Valeriani V, Simpson C, Jover T, McCulloch J, Dewar D (2000): The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J Cereb Blood Flow Metab 20:1529–1536.
- Mallard EC, Gunn AJ, Williams CE, Johnston BM, Gluckman PD (1992): Transient umbilical cord occlusion causes hippocampal damage in fetal sheep. Am J Obstet Gynecol 167:1423–1430.
- Markes KA, Mallard EC, Roberts I,Williams CE, Sirimanne ES, Johnston BM, Gluckman PD, Edwards AD (1996): Delayed vasodilatation and altered oxygenation after cerebral ischemia in fetal sheep. Pediatr Res 39:48–54.
- Masaoka N, Hayakawa Y, Ohgame S, Sakata H, Satoh K, Takahashi H (1998): Changes in purine metabolism and production of oxygen free radicals by intermittent partial umbilical cord occlusion in chronically instrumented fetal lambs. J Obstet Gynaecol Res 24:63–71.
- Menendez-Pelaez A, Reiter RJ (1993): Distribution of melatonin in mammalian tissues: The relative importance of nuclear versus cytosolic localization. J Pineal Res 15:59–69.
- Mishra OP, Delivoria-Papadopoulos M (1988): Anti-oxidant enzymes in fetal guinea pig brain during development and the effect of maternal hypoxia. Brain Res 470:173–179.
- Mishra OP, Delivoria-Papadopoulos M (1989): Lipid peroxidation in developing fetal guinea pig brain during normoxia and hypoxia. Brain Res Dev Brain Res 45:129–135.
- Mitchel RE (1979): On the mechanism of oxygen protection against ionizing radiation damage in the cell wall of Micrococcus radiodurans. Radiat Res 79:63–76.
- Neely MD, Sidell KR, Graham DG, Montine TJ (1999): The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem 72:2323–2333.
- Okatani Y, Okamoto K, Hayashi K, Wakatsuki A, Tamura S, Sagara Y (1998): Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 25:129–134.
- Okatani Y, Wakatsuki A, Kaneda C (2000): Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 28:89–96.
- Orrenius S, McConkey DJ, Bellomo G, Nicotera P (1989): Role of Ca2+ in toxic cell killing. Trends Pharmacol Sci 10:281–285.
- Oxenkrug G, Requintina P, Bachurin S (2001): Antioxidant and antiaging activity of N-acetylserotonin and melatonin in the in vivo models. Ann NY Acad Sci 939:190–199.
- Pablos MI, Chuang J, Reiter RJ, Ortiz GG, Daniels WM, Sewerynek E, Melchiorri D, Poeggeler B (1995): Time course of the melatonin-induced increase in glutathione peroxidase activity in chick tissues. Biol Signals 4:325–330.
- Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC (1993): Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis. J Pineal Res 14:151–168.
- Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LR (1994): Melatonin – A highly potent endogenous radical scavenger and electron donor: New aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci 738:419–420.
- Powell SR, Wahezi SE, Maulik D (2002): The effect of in utero hypoxia on fetal heart and brain trace metals. J Trace Elem Med Biol 16:245–248.
- Raad RA, Tan WKM, Bennet L, Gunn A, Davis S, Gluckman PD, Johnston BM, Williams CE (1999): Role of cerebrovascular and metabolic responses in the delayed phases of injury after transient cerebral ischemia in fetal sheep. Stroke 30:2735–2741.
- Rantonen T, Kaapa P, Gronlund J, Ekblad U, Helenius H, Kero P, et al (2001): Maternal magnesium sulfate treatment is associated with reduced brain blood flow perfusion in preterm infants. Crit Care Med 29:1460–1465.
- Reiter RJ (1991): Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr Rev 12:151–180.
- Reiter RJ (1995): The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem Int 27:453–460.
- Reiter RJ (1998): Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 56:359–384.
-
Reiter RJ, Tan D, Osuna C, Gitto E (2000): Actions of melatonin in the reduction of oxidative stress J Biomed Sci 7:444–458.
- Roelfsema V, Bennet L, George S, Wu D, Guan J, Veerman M, Gunn AJ (2004): Window of opportunity of cerebral hypothermia for postischemic white matter injury in the near-term fetal lamb. J. Cereb Blood Flow Metab 24:877–886.
- Sadowsky DW, Yellon S, Mitchell MD, Nathanielz PW (1991): Lack of effect of melatonin on myometrial electromyographic activity in the pregnant sheep at 138–142 days gestation (term = 147 days gestation). Endocrinology 128:1812–1818.
- Siesjo B, Elmer E, Janelidze S, Keep M, Kristian T, Ouyang YB, Uchino H (1999): Role and mechanisms of secondary energy failure. Acta Neuochir Suppl 73:7–13.
- Ste-Marie L, Vachon P, Vachon L, Bemeur C, Guertin MC, Montgomery J (2000): Hydroxyl radical production in the cortex and striatum in a rat model of focal cerebral ischemia. Can J Neurol Sci 27:152–159.
- Tan WK, Williams CE, During MJ, Mallard EC, Gunning MI, Gunn AJ, Gluckman PD (1996): Accumulations of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep. Pediatr Res 39:791–797.
- Venditti P, Masullo P, Di Meo S (2001): Effects of myocardial ischemia and reperfusion on mitochondrial function and susceptibility to oxidative stress. Cell Mol Life Sci 58:1528–1537.
- Voultsios A, Kennaway DJ, Dawson D (1997): Salivary melatonin as a circadian phase marker: Validation and comparison with plasma melatonin. J Biol Rhythms 12:457–466.
-
Yan EB, Miller SL, Castillo-Melendez M, Walker DW (2005): A novel method for in vivo hydroxyl radical measurements. J Appl Physiol, doi: 10.1152/japplphysiol.00617.2004.
Article / Publication Details
Received: August 13, 2004
Accepted: December 20, 2004
Published online: July 19, 2005
Issue release date: March – August
Number of Print Pages: 11
Number of Figures: 5
Number of Tables: 1
ISSN: 0378-5866 (Print)
eISSN: 1421-9859 (Online)
For additional information: https://www.karger.com/DNE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
